Ampio Pharmaceuticals (AMPE)

Revenue in 2023 (TTM): N/A

a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ampio Pharmaceuticals from 2009 to 2023

Annual revenue

Year	Revenue	Change
2023	N/A
2022	N/A
2021	N/A
2020	N/A
2019	N/A
2018	N/A
2017	N/A
2016	N/A	-100%
2015	HK$3.63 M	510.6%
2014	HK$0.59 M	53.62%
2013	HK$0.38 M	0.04%
2012	HK$0.38 M	166.13%
2011	HK$0.14 M
2010	N/A
2009	N/A

Revenue for similar companies or competitors

Company	Revenue	Revenue differencediff.	Country
Aerie Pharmaceuticals AERI	HK$1.66 B	N/A	🇺🇸 USA
Johnson & Johnson JNJ	HK$682.13 B	N/A	🇺🇸 USA
Flexion Therapeutics FLXN	HK$0.78 B	N/A	🇺🇸 USA
Rigel Pharmaceuticals RIGL	HK$1.01 B	N/A	🇺🇸 USA
Abbott Laboratories ABT	HK$320.60 B	N/A	🇺🇸 USA
Regeneron Pharmaceuticals REGN	HK$107.70 B	N/A	🇺🇸 USA
Pfizer PFE	HK$432.80 B	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Revenue for Ampio Pharmaceuticals (AMPE)

Revenue in 2023 (TTM): N/A